Alice Lorusso Publishes Study on Optimized Pathogen Reduction for Double-Dose Platelets
Alice Lorusso, Senior Medical Scientist at Irish Blood Transfusion Service, posted on LinkedIn:
”Thrilled to share that my paper “Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI system” has been published in Vox Sanguinis.
This study explores how double-dose platelet components can be safely pathogen-reduced while maintaining excellent in-vitro quality and compliance with EDQM specifications.
Grateful to my co-authors and colleagues for the teamwork and dedication that made this possible ”
Read the full article here.
Title: Optimized pathogen reduction of double-dose platelets pooled from seven buffy coats using the TACSI® system
Authors: Alice Lorusso, Liam Morgan, Aileen Farrelly, Mark Lambert, Barry Doyle, Paul Hendrick, Einas Elsheikh, Andrew Godfrey, Tor Hervig, Allison Waters
Stay updated with Hemostasis Today.
-
Jun 30, 2026, 04:12Maia Meier: Driving Change for Women and Girls with Bleeding Disorders
-
Jun 30, 2026, 03:19Wolfgang Miesbach: Weight-Bearing Lunge Test for Ankle Assessment in Haemophilia?
-
Jun 30, 2026, 03:06Salvatore Brugaletta: Is Twelve Months of DAPT Still Too Long After ACS?
-
Jun 30, 2026, 02:55Edward Lee Carter: How A Landmark Stewardship Shift Reduced Unnecessary Antiplatelet Use Across VISN 8
-
Jun 30, 2026, 02:43Nicolas Gendron: More than a Research Fellowship – Leaving the Wagner Lab
-
Jun 30, 2026, 02:29Wolfgang Miesbach: Can We ‘Pre‑Tame’ the Immune System to Unlock Better AAV8 FVIII Expression?
-
Jun 30, 2026, 02:21Mohammad Khalil: Evaluating DAPT Duration after Percutaneous Coronary Intervention
-
Jun 30, 2026, 02:11Rishdha Roshad: Activated Clotting Time – Adult vs Pediatric
-
Jun 30, 2026, 02:02Julia Castillo González: Role of Cortistatin During the Acute and Subacute Phases of Ischemic Stroke